Erudio Healtherudio.com
Indication
Hormone receptor-positive breast cancer trials: what clinicians said in public
No HCP commentary report on a trial in hormone receptor-positive breast cancer yet. Erudio has found public clinician commentary on 3 clinical trials in hormone receptor-positive breast cancer: ADELA, DATO-BASE and TREAT ctDNA. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| TREAT ctDNA NCT05512364 · European Organisation for Research and Treatment of Cancer - EORTC DeepView → | ER+/HER2- breast cancer with ctDNA relapse | Phase 3 | Deep | View | |||
| DATO-BASE NCT06176261 · Nancy Lin, MD DeepView → | Not given | Phase 2 | Deep | View | |||
| ADELA NCT06382948 · MedSIR StandardView → | ESR1-mutated ER+/HER2- advanced breast cancer after CDK4/6 inhibitors | Phase 3 | Standard | View | |||